Supplemental Figure S5 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma
Year: 2026
Type: supplementary-materials
Abstract: TOP2 poisons synergize with DNA-PK inhibition in EWS
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W7165054022
Cites:
Cited by:
Related to:
